Sunday, 29th of July 2012 |
PROJECTING THE BENEFITS OF ANTIRETROVIRAL THERAPY FOR HIV PREVENTION: THE IMPACT OF POPULATION MOBILITY AND LINKAGE TO CARE
1. Jason R. Andrews1, Robin Wood4, Linda-Gail Bekker4, Keren Middelkoop4 and
+ Author Affiliations
1. 1Division of Infectious Diseases, Massachusetts General Hospital
2. 2Division of General Medicine, Department of Medicine, Massachusetts General HospitalBoston
3. 3Harvard University Center for AIDS Research, Harvard Institute for Global Health CambridgeMassachusetts
4. 4Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Republic of South Africa
1. Correspondence: Jason R. Andrews, MD, Division of Infectious Diseases, Massachusetts General Hospital, 50 Staniford St, 9th Fl, Boston, MA 02114 (jandrews6@partners.org).
Abstract below; full text available to JID subscribers
Background. Recent mathematical models suggested that frequent human immunodeficiency virus (HIV) testing with immediate initiation of antiretroviral therapy (ART) to individuals with a positive test result could profoundly curb transmission. The debate about ART as prevention has focused largely on parameter values. We aimed to evaluate structural assumptions regarding linkage to care and population mobility, which have received less attention.
Methods. We modified the linkage structure of published models of ART as prevention, such that individuals who decline initial testing or treatment do not link to care until late-stage HIV infection. We then added population mobility to the models. We populated the models with demographic, clinical, immigration, emigration, and linkage data from a South African township.
Results. In the refined linkage model, elimination of HIV transmission (defined as an incidence of <0.1%) did not occur by 30 years, even with optimistic assumptions about the linkage rate. Across a wide range of estimates, models were more sensitive to structural assumptions about linkage than to parameter values. Incorporating population mobility further attenuated the reduction in incidence conferred by ART as prevention.
Conclusions. Linkage to care and population mobility are critical features of ART-as-prevention models. Clinical trials should incorporate relevant data on linkage to care and migration to evaluate the impact of this strategy.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41232566 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |